Home > News > Nanogen Expands Molecular Diagnostic Product Menu
March 6th, 2003
Nanogen Expands Molecular Diagnostic Product Menu
Abstract:
Nanogen announced today that it has commercially released the first multiplex Analyte Specific Reagent, designed for the detection of Factor V Leiden and Factor II Prothrombin gene mutations associated with cardiovascular disease and the pathology of thrombosis.
Source:
Nanogen
Related News Press |
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||